All research
Oxytocin 2016-10-01 ClinicalTrials

Oxytocin and Propranolol combination effect on labor induction compared to oxytocin alone in term pregnancy

A Comparison Between the Effect of Oxytocin Only and Oxytocin Plus Propranolol on Induction of Labor in Term Pregnancy

Background

Induction of labor is a common obstetric procedure when continuation of pregnancy poses risks to mother or fetus. Oxytocin is the primary agent used to stimulate uterine contractions, but its efficacy can vary, and prolonged labor or failed induction can lead to complications like cesarean delivery. Exploring adjuncts that can optimize oxytocin's action or improve labor progression is crucial for better maternal and neonatal outcomes. Beta-adrenergic receptors in the uterus can modulate contractility, suggesting that their blockade might enhance oxytocin's effects.

Study Design

This study aimed to compare two distinct regimens for induction of labor in term pregnancy. One intervention arm received Oxytocin combined with Oral Propranolol, while the control arm received Oxytocin only. The primary objective was to assess the comparative effect of these two approaches on labor induction outcomes. Specific details regarding the exact patient numbers, precise dosing protocols for Oxytocin or Propranolol, administration routes, frequency, or duration of treatment were not provided in the abstract, nor were the specific primary endpoints (e.g., duration of labor, success rate) explicitly stated.

Why It Matters

If Propranolol proves to enhance Oxytocin's efficacy or reduce induction time, it could offer a novel, readily available adjunct to current labor induction protocols. This could potentially lead to shorter labor durations, reduced need for higher oxytocin doses, or lower rates of cesarean delivery in term pregnancies, thereby improving maternal and neonatal outcomes. Such a finding would warrant further investigation into optimal dosing, timing, and safety profiles for this combination, potentially impacting obstetric practice by providing a new strategy to improve labor outcomes and reduce associated complications. Optimizing labor induction protocols could significantly benefit patient care.


oxytocin propranolol labor induction pregnancy obstetrics clinical trial
Source: clinicaltrials:NCT03533699 · Ingested 2026-07-13 · Digest: gemini-2.5-flash